What do you need to ask during the vetting and selection process to ensure your clinical or commercial program won’t be derailed by a quality-related problem?
Ania Szymanska
Advertisement
Ania Szymanska is site head of Quality at Scorpius Biomanufacturing.
Articles by Ania Szymanska
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
